Avandia is now likely to get stricter labeling due to increase in heart attacks. The FDA recommended this to the advisory panel and added that they are not necessarily initiatiating patients to switch medications.
Dr Clifford Rosen of St Joseph Hospital in Maine, who chaired the FDA meeting, said in an interview that “sometimes the older drugs work just as well” at lowering diabetics’ blood sugar levels, which is why Avandia and other diabetes drugs are used in the first place. Older products include metformin and sulfonylureas, and while they also have side effects, he said physicians generally know what to expect with them.
For more information on this subject, please refer to our section on Drugs, Medical Devices, and Implants.
The Legal Examiner and our Affiliate Network strive to be the place you look to for news, context, and more, wherever your life intersects with the law.
Comments for this article are closed.